SignalXSignalX

ALMS ALUMIS INC.

Q3 2025 10-Q
Filed: Nov 13, 2025Period ending Sep 30, 2025
Health Care
Pharmaceutical PreparationsSEC EDGAR
ALUMIS INC. Overview

ALUMIS INC. (ALMS) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 13, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • New litigation risk from securities class action lawsuit post-ACELYRIN Merger alleging disclosure violations in Phase 2b trial, motion to dismiss pending as of May 3, 2024
  • • Updated market risk: post-merger stock ownership split 52% vs 48% increases potential stock price volatility due to large share sales
+3 more insights

Get deeper insights on ALUMIS INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.